Sponsor or institution
Clinical trials and research at RayzeBio, Inc.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by RayzeBio, Inc. that are recruiting, at sites in 6 countries (most in United States (3), Canada (2), Australia (2)). By phase: Phase 1/2 (2), Early Phase 1 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Imaging study to see how the imaging agent distributes in metastatic clear cell RCC | Early Phase 1 | Saint Leonards, New South Wales and 5 other locations | Recruiting | Jun 26, 2026 |
| Imaging Test for Metastatic Urothelial and Breast C cancers and NSCLC | Early Phase 1 | St Leonards, New South Wales and 5 other locations | Recruiting | Jun 26, 2026 |
| RYZ401 for solid tumors that express somatostatin receptors | Phase 1 | Phoenix, Arizona and 14 other locations | Recruiting | Sep 10, 2025 |
| Using RYZ811 and RYZ801 to identify and treat patients with advanced liver cancer | Phase 1/2 | Birmingham, Alabama and 12 other locations | Recruiting | Dec 10, 2024 |
| Treatment for advanced breast cancer using RYZ101 | Phase 1/2 | Phoenix, Arizona and 30 other locations | Recruiting | Sep 19, 2024 |
All recruiting trials (5)
-
Imaging study to see how the imaging agent distributes in metastatic clear cell RCC
This imaging study tests an imaging agent in adults with metastatic clear cell renal cell carcinoma to see how it spreads and what dose is needed.
-
Imaging Test for Metastatic Urothelial and Breast C cancers and NSCLC
This imaging study tests how well the imaging agent works in people with metastatic urothelial cancer, various breast cancers, or NSCLC.
-
RYZ401 for solid tumors that express somatostatin receptors
This trial will try RYZ401, a targeted radiotherapy, in adults with neuroendocrine or other solid tumors that show somatostatin receptors to find a safe dose and see if it shrinks tumors.
-
Using RYZ811 and RYZ801 to identify and treat patients with advanced liver cancer
This study is testing a new way to find and treat people with advanced liver cancer using two agents, RYZ811 for diagnosis and RYZ801 for treatment, to see how well they work together.
-
Treatment for advanced breast cancer using RYZ101
This study is testing a new treatment called RYZ101 for people with advanced breast cancer that can't be removed by surgery to see if it helps manage their condition.
Quick answers
How many clinical trials run by RayzeBio, Inc. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), Canada (2 trials), Australia (2 trials), New Zealand (2 trials), South Africa (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Early Phase 1: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.